This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Dagmar Dasha Cabel: Innovator in Chemokine Receptor Research
Introduction
Dagmar Dasha Cabel is a prominent inventor based in Tucson, AZ (US). She has made significant contributions to the field of biomedical research, particularly in the development of compounds that target chemokine receptors. Her work is crucial for advancing treatments for various diseases.
Latest Patents
Dagmar holds a patent for "Inhibitors of the chemokine receptor CxCR3." This invention is directed to a 3-(amido or sulphamido)-4-(4-substituted-azinyl)benzamide or benzsulphonamide compound. The compound is useful as an inhibitor of the chemokine receptor CxCR3, which plays a role in preventing or treating diseases related to this receptor in patients.
Career Highlights
Dagmar is currently associated with Sanofi, a leading global healthcare company. Her innovative work has led to the development of important therapeutic agents that can significantly impact patient care.
Collaborations
Some of her notable coworkers include Martin Smrcina and David Squire Thorpe. Their collaborative efforts contribute to the advancement of research in the field.
Conclusion
Dagmar Dasha Cabel is a key figure in the realm of chemokine receptor research, with her patent and work at Sanofi highlighting her contributions to medical science. Her innovations pave the way for new treatments and improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile